RE104 for Adjustment Disorder in Cancer and Other Illnesses

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Recruiting Phase 2 Interventional Study
Adjustment Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
Reunion Neuroscience Inc · Industry
Who this trial is looking for

This trial is looking for people who have been diagnosed with Adjustment Disorder due to cancer or certain other health conditions. Participants will receive a single dose of the study drug to see if it helps reduce their depressive or anxiety symptoms.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have a history of Adjustment Disorder for at least 4 weeks.
  • I have been diagnosed with cancer, ALS, MS, PD, or IPF.
  • I can take care of myself and follow study procedures.
  • I have normal cognitive function.
  • I have been stable on my antidepressants or therapy or can wait to start them.
  • If I am female, I am not pregnant or planning to become pregnant.
  • If I am male, I am not planning to make a partner pregnant.
  • I am willing to follow the study's rules.

You may not be able to join if

  • I have a significant risk of suicide.
  • I have a history of bipolar disorder or psychosis.
  • I have an active central nervous system cancer.
  • I have other serious medical conditions that make me unsuitable.
  • I have used prohibited medications or treatments.
  • I am sensitive or intolerant to the study drug or rescue medications.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Has a ≥4 week history of AjD as defined by DSM-5-TR with either depressed mood, or mixed anxiety and depressed mood confirmed by clinical interview with evidence that the AjD was instigated by one of the following medical illnesses (e.g., diagnosis, impact, management, recurre…
Contacts

Mark Pollack, Chief Medical Officer

1-888-880-REUN

info@reunionneuro.com

CONTACT